HemaCare Corporation (HEMA) today reported its financial results for the six months and year ended December 31, 2012. For the six month period, revenue rose by 13% to $9.2 million, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year ended December 31, 2012, revenue rose by 10% to $17.9 million, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period. Total Company income was $1,163,000 for the year ended December 31, 2012 compared with a total Company loss of $805,000 for the year ended December 31, 2011.
